Harry Z. Rosengart
Fondateur chez Sunpharm Corp.
Profil
Mr. Rosengart is President and CEO of HK & Associates, an investment and consulting firm, specializing in financial and strategic advice to small and medium-sized companies with an emphasis on life sciences.
He is also the founder of LigoTech, Inc., a privately held DNA/RNA and macromolecule bioseparations company employing 14 individuals.
For three years, he served as Chairman of its Board of Directors, President and CEO and is currently a Member of the Board of Directors.
He raised $5 million in two equity rounds of capital.
During his tenure, he consummated several licensing transactions, acquired Affinity Biotechnology and successfully integrated the acquisition into LigoTech and launched a number of products.
Mr. Rosengart is also co-founder of SunPharm Corporation, an anti-cancer drug development-stage company.
Mr. Rosenhart is active in a number of civic and professional organizations and holds a B.S.
in Chemical Engineering and an MBA from Rutgers University.
Postes actifs de Harry Z. Rosengart
| Sociétés | Poste | Début |
|---|---|---|
Sunpharm Corp.
 Sunpharm Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sunpharm Corp. is a company that develops small molecule pharmaceutical products. The company is based in Jacksonville, FL. The company was founded by Harry Z. Rosengart. Sunpharm was acquired by GelTex Pharmaceuticals, Inc. on November 17, 1999 for $12.16 million. | Fondateur | 10/09/2009 |
Emerald Asset Management, Inc.
 Emerald Asset Management, Inc. Investment ManagersFinance Part of Emerald Asset Management Employee Stock Ownership Trust, Emerald Asset Management, Inc. is a diversified investment management holding company that manages client funds through its subsidiaries. The company is based in Lancaster, PA. The company's subsidiaries include Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Emerald Separate Account Management LLC, and Emstone Advisers LLC. The company's investment philosophy is research-focused and it primarily focuses on growth-oriented equity investing and income-oriented investing. The company manages assets worth approximately $3.80 billion as of December 31, 2022. The company was founded by Joseph Edward Besecker and he has been the CEO since incorporation. | Corporate Officer/Principal | 10/09/2009 |
Anciens postes connus de Harry Z. Rosengart
| Sociétés | Poste | Fin |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Président | 18/06/2008 |
Emerald Research
 Emerald Research Investment ManagersFinance Founded in 1992 by Joseph Besecker, Emerald Research is a research firm located in Leola, Pennsylvania. The firm is the investment research arm of Emerald Asset Management, Inc. and is affiliated with registered investment advisor Emerald Advisors, Inc. They focus on providing in-depth, on-site fundamental research of primarily small- to mid-cap public companies in the consumer, financial services, life sciences and technology sectors. Emerald's intense fundamental research process results in over 2000 company visits per year. The firm seeks to identify early investment opportunities that are included in a variety of growth-oriented separate account and mutual fund equity portfolios. Their parent firm, Emerald Asset Management, also offers short, mid and long-term fixed-income separate account strategies which utilize a combination of proprietary quantitative models and fundamental analysis to create portfolios of high quality liquid securities. | Analyst-Equity | - |
Formation de Harry Z. Rosengart
| Rutgers State University of New Jersey | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DYADIC INTERNATIONAL, INC. | Health Services |
| Entreprise privées | 3 |
|---|---|
Emerald Research
Emerald Research Investment ManagersFinance Founded in 1992 by Joseph Besecker, Emerald Research is a research firm located in Leola, Pennsylvania. The firm is the investment research arm of Emerald Asset Management, Inc. and is affiliated with registered investment advisor Emerald Advisors, Inc. They focus on providing in-depth, on-site fundamental research of primarily small- to mid-cap public companies in the consumer, financial services, life sciences and technology sectors. Emerald's intense fundamental research process results in over 2000 company visits per year. The firm seeks to identify early investment opportunities that are included in a variety of growth-oriented separate account and mutual fund equity portfolios. Their parent firm, Emerald Asset Management, also offers short, mid and long-term fixed-income separate account strategies which utilize a combination of proprietary quantitative models and fundamental analysis to create portfolios of high quality liquid securities. | Finance |
Sunpharm Corp.
Sunpharm Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sunpharm Corp. is a company that develops small molecule pharmaceutical products. The company is based in Jacksonville, FL. The company was founded by Harry Z. Rosengart. Sunpharm was acquired by GelTex Pharmaceuticals, Inc. on November 17, 1999 for $12.16 million. | Health Technology |
Emerald Asset Management, Inc.
Emerald Asset Management, Inc. Investment ManagersFinance Part of Emerald Asset Management Employee Stock Ownership Trust, Emerald Asset Management, Inc. is a diversified investment management holding company that manages client funds through its subsidiaries. The company is based in Lancaster, PA. The company's subsidiaries include Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Emerald Separate Account Management LLC, and Emstone Advisers LLC. The company's investment philosophy is research-focused and it primarily focuses on growth-oriented equity investing and income-oriented investing. The company manages assets worth approximately $3.80 billion as of December 31, 2022. The company was founded by Joseph Edward Besecker and he has been the CEO since incorporation. | Finance |
